Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve
September 26th, 2018
12.8K views
Here, we present a protocol to inject autologous muscle-derived stem cells in the proximity to the recurrent laryngeal nerve with the help of an electrical nerve stimulator. This novel technique may become useful for the treatment of equine recurrent laryngeal neuropathy.
Overview
This article presents a novel protocol for injecting autologous muscle-derived stem cells near the recurrent laryngeal nerve using an electrical nerve stimulator. This technique aims to provide a minimally invasive treatment option for equine recurrent laryngeal neuropathy.
Key Study Components
Area of Science
- Regenerative medicine
- Stem cell therapy
- Neurology
Background
- Equine recurrent laryngeal neuropathy is a common condition affecting horses.
- Current treatments may be invasive and less effective.
- Stem cell therapy has potential for treating peripheral neuropathies.
- This method allows for the collection and injection of stem cells in a minimally invasive manner.
Purpose of Study
- To develop a protocol for stem cell injection near the recurrent laryngeal nerve.
- To evaluate the effectiveness of this technique in treating equine recurrent laryngeal neuropathy.
- To explore the broader implications for other peripheral neuropathies.
Methods Used
- Identification of the muscle sample site using visual inspection and palpation.
- Collection of muscle-derived stem cells using a biopsy needle.
- Injection of stem cells guided by electrical nerve stimulation.
- Monitoring of laryngeal function pre- and post-injection.
Main Results
- No adverse reactions were observed during or after the procedure.
- Laryngeal function scores remained consistent before and after the injection.
- The technique allows for the culture of a large number of autologous mesenchymal stem cells.
- Potential for application in other studies involving different cell types.
Conclusions
- The developed technique is a promising approach for treating equine recurrent laryngeal neuropathy.
- It provides a foundation for further research into stem cell applications in regenerative medicine.
- Future studies may explore the use of pre-differentiated cells for nerve regeneration.
Frequently Asked Questions
What is equine recurrent laryngeal neuropathy?
It is a condition affecting horses that impairs their ability to breathe properly due to nerve dysfunction.
How are stem cells collected for this procedure?
Stem cells are collected from the long head of the triceps muscle using a minimally invasive biopsy technique.
What role does the electrical nerve stimulator play?
It helps to identify the recurrent laryngeal nerve during the injection process by stimulating muscle response.
Are there any risks associated with this technique?
No adverse reactions or inflammation have been reported in previous studies.
Can this technique be applied to other conditions?
Yes, the injection method may be adapted for other peripheral neuropathies.
What is the significance of using autologous stem cells?
Using autologous stem cells reduces the risk of rejection and complications associated with donor cells.
Executive Industry Relevance
This protocol establishes a minimally invasive method for targeted delivery of autologous stem cells to peripheral nerves using electrical nerve stimulation guidance. The approach supports mechanistic de-risking in regenerative medicine by enabling precise cellular intervention in neuropathic conditions. It provides a translatable framework for evaluating stem cell therapies in peripheral nerve repair, with implications for preclinical target validation and assay development in neurology-focused drug discovery programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of stem cell mechanisms in demyelinated peripheral nerve models.
- Operational Value: Provides a reproducible nerve localization technique using stimulation thresholds to confirm target engagement.
Screening & Assay Development
- Scientific Value: Generates quantitative functional readouts via laryngeal movement scoring to assess biological activity.
- Operational Value: Establishes standardized endpoints for pre- and post-intervention comparison across timepoints.
Translational & Preclinical Research
- Scientific Value: Supports continuity from discovery to preclinical validation in large animal models of neuropathy.
- Operational Value: Demonstrates feasibility of autologous cell processing and delivery without observed adverse effects.
Pipeline & Workflow Integration
The method integrates into discovery biology workflows by enabling hypothesis testing around cellular mechanisms in peripheral neuropathy, with direct relevance to lead identification stages where target modulation and functional rescue are evaluated.
- Discovery Biology: Facilitates mechanistic de-risking by allowing controlled delivery of therapeutic cells to validated neural targets.
- Screening: Produces quantifiable functional outcomes through blinded endoscopic scoring of motor response.
- Analytics: Enables longitudinal assessment of biological effect using repeated functional measurements.
- Translational Research: Bridges equine neuropathy models to human peripheral nerve repair strategies through conserved stimulation-guided delivery principles.
- Enterprise Reuse: Establishes a reusable platform for nerve-targeted cell delivery applicable across multiple cell types and neuropathic indications.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in stem cell-mediated nerve repair through precise peri-neuronal delivery.
- Operational Value: Ensures reproducibility via nerve stimulator-guided injection and blinded functional assessment.
- Strategic Value: Improves go/no-go decisions by providing early safety and functional response data in relevant disease models.
- Portfolio Impact: Supports risk-adjusted advancement by demonstrating feasibility of autologous stem cell use in neuropathy models.
Implementation Considerations
- Requires expertise in equine anatomy, nerve stimulation techniques, and endoscopic laryngeal evaluation.
- Depends on sterile surgical setup, nerve stimulator equipment, and video endoscopy infrastructure.
- Necessitates standardized training for consistent needle placement and stimulation threshold identification.
- Involves adaptation considerations for different nerve access routes and species-specific anatomy.
- Limited to procedures where motor response can be elicited and monitored via accessible effector organs.
Biopharma FAQs
Why does nerve stimulator guidance matter for target validation in peripheral neuropathy models?
Nerve stimulator guidance enables precise localization of the recurrent laryngeal nerve by identifying the minimal current that produces a motor response, confirming accurate needle placement before stem cell injection. This approach reduces off-target delivery risk and increases confidence in target engagement during preclinical studies.
How does isolating the motor response variable support discovery pipeline progression?
Isolating the motor response as a binary endpoint allows researchers to correlate stimulation intensity with neural activation, providing a reliable assay for nerve accessibility and functional integrity. This variable serves as a mechanistic readout to evaluate procedural consistency across experimental replicates.
What do repeated quantitative laryngeal function measurements enable in therapeutic assessment?
Repeated blinded scoring of laryngeal movement at defined intervals (pre-treatment, day 1, 7, and 28) enables longitudinal assessment of biological effect and detection of any functional changes following stem cell delivery. These measurements support objective comparison of pre- and post-intervention states in efficacy evaluation.
Why are replication requirements important for cross-functional collaboration in nerve-targeted studies?
Replication across multiple animals and timepoints ensures that observed outcomes are consistent and not attributable to procedural variability, building confidence in the method’s reliability. This consistency is essential for translating findings between discovery, translational, and preclinical teams working on neuropathy models.
What statistical analysis capabilities are required before implementing stimulation-guided cell injection in discovery workflows?
Implementation requires the ability to perform longitudinal comparison of functional scores using non-parametric or repeated measures tests to assess significance across timepoints. Researchers must also be equipped to analyze inter-observer variability in blinded endoscopic scoring to ensure data robustness.
